Being Overweight Just As Risky To Health As Being A Smoker

Obese adolescents have the same risk of premature death in adulthood as people who smoke more than 10 cigarettes a day, while those who are overweight have the same risk as less heavy smokers, according to research published on http://www.bmj.com today. Smoking and obesity are two of the most important behavioural risk factors for premature […]

Heart Drugs: Brand Names No Better Than Generics, Study

US scientists reviewing 20 years of research and expert opinion on generic versus brand name drugs in the treatment of cardiovascular diseases found no clinical evidence showing brand names were superior to generic versions even though a substantial number of experts writing editorials advised against interchanging them. The study was the work of Dr Aaron […]

HIV/AIDS Experts, Doctors Voice Concerns About Health Problems Seen Among Long-Term HIV/AIDS Survivors

Some experts and doctors recently have voiced concerns that people who were diagnosed with HIV/AIDS in the early years of the epidemic are experiencing “prematur[e]” or “disproportionate numbers” of ailments associated with aging, the New York Times reports. CDC estimates show that the number of people ages 50 and older living with HIV increased by […]

Heart Disease Risk May Increase With Lack Of Vitamin D

The same vitamin D deficiency that can result in weak bones now has been associated with an increased risk of cardiovascular disease, Framingham Heart Study researchers report in Circulation: Journal of the American Heart Association. “Vitamin D deficiency is associated with increased cardiovascular risk, above and beyond established cardiovascular risk factors,” said Thomas J. Wang, […]

CryoCor Reports Publication In Circulation For Treatment Of Atrial Fibrillation

CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced the publication of a European study of atrial fibrillation patients treated with CryoCor’s Cardiac Cryoablation System. The purpose of the study was to evaluate the role of atrial flutter in the recurrence of atrial fibrillation and the effectiveness of […]

Do It Yourself Cardiac Bypass Surgery

When cholesterol-clogged plaque narrows an artery that feeds the heart, the body responds by trying to bulk up tiny blood vessels in the heart. As these so-called collateral vessels grow more muscular and interconnected, they begin to reroute some of the blood flow around the blockage. Scientists have been trying for years to nudge collateral […]

Cardiac Stem Cell Therapy Closer To Reality

Since the year 2000, much has been learned about the potential for using transplanted cells in therapeutic efforts to treat varieties of cardiac disorders. With many questions remaining, the current issue of CELL TRANSPLANTATION (Vol.16 No. 9), The Proceedings of the Third Annual Conference on Cell Therapy for Cardiovascular Disease, presents research aimed at answering […]

Patient With AIDS Finds Heart-Assit Device Is An Option When Transplant Is Not

Josh Bristow was in the late stages of heart failure when he came to the Emergency Department at Cedars-Sinai Medical Center on Aug. 25, 2007. Medications and the earlier implantation of a pacemaker had given him some time, but the 51 year old Studio City man’s heart could no longer supply the blood and oxygen […]

Expert Evidence To House Of Lords Committee States Aspirin Of Doubtful Value To Prevent DVT

A University of Leicester academic has given evidence to the House of Lords’ Science and Technology Committee. Dr William Toff, Senior Lecturer in Cardiology, gave expert evidence to the inquiry on Air Travel and Health. He told the committee that, “for the average traveller, the use of aspirin is a relatively ineffective intervention” in the […]

NDA Accepted For Tolvaptan, Investigational Drug For Worsening Heart Failure And Hyponatremia

Otsuka Pharmaceutical Development & Commercialization, Inc. announced recently that the U.S. Food and Drug Administration has accepted a new drug application (NDA) for the company’s investigational oral once-daily medication tolvaptan, a selective V2-vasopressin receptor antagonist, for two indications: treatment of adults with worsening heart failure and treatment of hyponatremia1. These indications are based on data […]